| Grace Marie Mignosa, LICSW | |
|
1138 Pine St, Burlington, VT 05401-5353 | |
| (802) 488-6600 | |
| (802) 488-6919 |
| Full Name | Grace Marie Mignosa |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1138 Pine St, Burlington, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043328180 | NPI | - | NPPES |
| 1012149 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 0890000584 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Grace Marie Mignosa, LICSW 208 Flynn Ave, Suite 3j, Burlington, VT 05401-5429 Ph: (802) 488-6900 | Grace Marie Mignosa, LICSW 1138 Pine St, Burlington, VT 05401-5353 Ph: (802) 488-6600 |
News Archive
DaVita, a division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, today announced that DaVita Hospital Services, the company's inpatient kidney care services, has received Ambulatory Health Care Accreditation from The Joint Commission.
IT and medical technology company Sectra's profit after net financial items for the company's first quarter, May - July 2011, rose 25.6% to SEK 16.2 million (12.9), corresponding to a profit margin of 9.6% (7.5). The Group reports an operating profit of SEK 6.5 million (9.0) and net sales of SEK 169.3 million (172.8). Order bookings rose 13.8% to SEK 190.8 million.
Physicians have known for decades that many premature babies suffer respiratory problems stemming from insufficiency of a lung substance called surfactant during their first few weeks of life.
New research suggests that ibuprofen may offer protection against developing Parkinson's disease, according to one of the largest studies to date investigating the possible benefits of the over-the-counter drug on the disease. The study is published in the March 2, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that data presented at a major medical meeting showed that its lead compound GLYX-13 demonstrated robust antidepressant-like and anxiolytic-like activity with no signs of the CNS-related side effects seen with other drugs targeting the NMDA receptor.
› Verified 7 days ago
Shannon Kadish, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1138 Pine St, Burlington, VT 05401 Phone: 802-488-6600 | |
Elyza Moore, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1138 Pine St, Burlington, VT 05401 Phone: 802-488-6000 Fax: 802-488-6919 | |
Ellyn Leamon, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1138 Pine St, Burlington, VT 05401 Phone: 802-863-1326 | |
Lauren Carpenter, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 617 Riverside Ave, Burlington, VT 05401 Phone: 802-864-6309 | |
Elaine Soto, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 300 Flynn Ave, Burlington, VT 05401 Phone: 802-488-6300 | |
Jenifer D'aiello, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1 S Prospect St, Burlington, VT 05401 Phone: 802-847-5331 Fax: 802-847-7765 | |
Kathleen Browne, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 617 Riverside Ave, Burlington, VT 05401 Phone: 802-864-6309 Fax: 802-860-4324 |